Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildalfa MF 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Alphard Pharmaceuticals Private Limited

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildalfa MF 500mg/50mg Tablet

Metformin/Vildagliptin 500mg/50mg tablets manage elevated blood glucose in type 2 diabetes patients by combining two active ingredients. This dual action mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk (heart attack, stroke). This medication may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is individualized, considering your health status, glycemic control, and other concurrent medications. Ingestion with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Effective blood sugar regulation prevents future complications. Continued adherence to your physician's dietary and exercise plan is crucial. Lifestyle modifications significantly impact diabetes management. Common adverse reactions include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, diaphoresis, and anorexia. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; understanding its recognition and management is essential. This medication is not universally suitable. Pre-treatment disclosure of kidney, liver, or heart conditions, pancreatic disorders, and excessive alcohol consumption is mandatory. Pregnant or lactating individuals require physician consultation before initiating treatment. Potential drug interactions necessitate complete disclosure of all medications to ensure safety. Alcohol consumption should be minimized due to its potential to reduce blood glucose levels. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Uses of Vildalfa MF 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildalfa MF 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vildalfa MF 500mg/50mg Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

Common Side effects of Vildalfa MF 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildalfa MF 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Vildalfa MF 500mg/50mg Tablet with a meal.

How Vildalfa MF 500mg/50mg Tablet works:

Each Vildalfa MF 500mg/50mg tablet combines two distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vildalfa MF 500mg/50mg Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vildalfa MF 500mg/50mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential dangers before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and the use of Vildalfa MF 500mg/50mg tablets are likely incompatible. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildalfa MF 500mg/50mg Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely not take Vildalfa MF 500mg/50mg tablets, and medical advice is recommended before use.

What if you forget to take Vildalfa MF 500mg/50mg Tablet :

Should you forget a Vildalfa MF 500mg/50mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Vildalfa MF 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildalfa MF 500mg/50mg Tablet

Vildalfa MF 500mg/50mg Tablets rarely cause hypoglycemia by themselves, but low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate low blood sugar. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advised.
Nausea and vomiting are possible side effects of Vildalfa MF 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Vildalfa MF 500mg/50mg Tablets are contraindicated in patients with known allergies to any component or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Vildalfa MF 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18 years of age.
Vildalfa MF 500mg/50mg Tablets can, rarely, cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Vildalfa MF and seek immediate medical attention.
Prolonged use of Vildalfa MF 500mg/50mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildalfa MF 500mg/50mg Tablet is safe when taken as prescribed. However, even with correct dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Vildalfa MF 500mg/50mg Ta...
110
MRP 127
13% off